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Malassezia spp. with an Optimized
Colorimetric Broth Microdilution Method
Cheryl Leong, Antonino Buttafuoco, Martin Glatz, Philipp P. Bosshard
Department of Dermatology, University and University Hospital of Zurich, Zurich, Switzerland
ABSTRACT Malassezia is a genus of lipid-dependent yeasts. It is associated with
common skin diseases such as pityriasis versicolor and atopic dermatitis and can
cause systemic infections in immunocompromised individuals. Owing to the slow
growth and lipid requirements of these fastidious yeasts, convenient and reliable an-
tifungal drug susceptibility testing assays for Malassezia spp. are not widely avail-
able. Therefore, we optimized a broth microdilution assay for the testing of Malasse-
zia that is based on the CLSI and EUCAST assays for Candida and other yeasts. The
addition of ingredients such as lipids and esculin provided a broth medium formula-
tion that enabled the growth of all Malassezia spp. and could be read, with the col-
orimetric indicator resazurin, by visual and ﬂuorescence readings. We tested the sus-
ceptibility of 52 strains of 13 Malassezia species to 11 commonly used antifungals.
MIC values determined by visual readings were in good agreement with MIC values
determined by ﬂuorescence readings. The lowest MICs were found for the azoles
itraconazole, posaconazole, and voriconazole, with MIC90 values of 0.03 to 1.0 g/ml,
0.06 to 0.5 g/ml, and 0.03 to 2.0 g/ml, respectively. All Malassezia spp. were resis-
tant to echinocandins and griseofulvin. Some Malassezia spp. also showed high MIC
values for ketoconazole, which is the most widely recommended topical antifungal
to treat Malassezia skin infections. In summary, our assay enables the fast and reli-
able susceptibility testing of Malassezia spp. with a large panel of different antifun-
gals.
KEYWORDS antifungal agents, antifungal susceptibility testing, fungi, Malassezia,
yeasts
Malassezia is a genus of lipid-dependent yeasts that currently includes 14 species.With the exception of Malassezia pachydermatis, Malassezia species are lipid
dependent. Malassezia sympodialis, Malassezia sloofﬁae, Malassezia furfur, Malassezia
globosa, Malassezia restricta, Malassezia obtusa, Malassezia japonica, Malassezia derma-
tis, and Malassezia yamatoensis are considered anthropophilic, as they have been
isolated from human skin (1). Malassezia is the most common fungal genus of the
healthy human skin microbiome (2). Additionally, a pathogenic role is attributed to
these yeasts in common skin diseases such as pityriasis versicolor, atopic dermatitis,
and seborrheic dermatitis, and they can cause severe systemic infections in neonates
and immunocompromised individuals (3, 4).
In infectious diseases, antimicrobial susceptibility testing is a useful tool to deter-
mine the appropriate antimicrobial treatment, particularly if antimicrobial susceptibility
cannot be predicted based on the identity of the infectious agent (5). Treatment of
Malassezia-related infections has thus far relied on the predicted susceptibility to
common antifungals such as topical azoles. However, the antifungal treatment of
Malassezia-associated skin diseases is not clinically efﬁcacious in up to one-third of
patients (6). This may be attributable to malcompliance as well as the antifungal
resistance of Malassezia spp. Moreover, knowledge regarding the susceptibility of
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different Malassezia species and strains to particular antifungals is scarce (7–10), which
supports the need for antifungal susceptibility testing for Malassezia spp. Existing
assays for determination of the MIC values for antifungals, as recommended by the CLSI
(11) and EUCAST (http://www.eucast.org) guidelines, are applicable only for fast-
growing fungi such as Candida spp. These assays are not suitable for Malassezia spp.,
which are slow growing and fastidious. Therefore, some studies that tested the anti-
fungal susceptibility of Malassezia spp. used assays modiﬁed from the CLSI and EUCAST
guidelines. The modiﬁcations included variations in growth medium composition and
inoculum size (Table 1) (7–9). Turbidity was the preferred readout method for most of
the assays (7, 8). However, drawbacks of turbidity readings include limited reproduc-
ibility and the possibility of underestimating MIC values (12). To overcome these
limitations, we have developed a new antifungal susceptibility assay, based on a broth
medium, that allows growth and reliable and convenient antifungal testing of all
Malassezia species. It is compatible with the ﬂuorometric indicator resazurin, enabling
the rapid and effective determination of MIC values by visual and ﬂuorescence read-
ings.
RESULTS
Growth of Malassezia spp. in OptiMAL broth medium. Serial dilutions of each
broth medium component were tested to determine the optimal concentrations for
ﬁve Malassezia species, i.e., M. sympodialis, M. sloofﬁae, M. furfur, M. globosa, and M.
pachydermatis. Optimal glycerol and Tween 60 concentrations were 0.25 to 0.5% and
0.5%, respectively. We used a concentration of 0.05 to 2% oleic acid for OptiMAL,
because most Malassezia species preferred oleic acid to olive oil in assimilation assays.
Glucose concentrations of more than 2% did not improve growth. The optimal pH
range was pH 6.0 to 6.5.
In the absence of sodium bicarbonate, RPMI and RPMI tended to color bleach.
Testing growth with sodium bicarbonate concentrations ranging from 0 to 32 mg/ml
showed that Malassezia spp. were able to tolerate sodium bicarbonate concentrations
of up to 2 mg/ml before growth inhibition occurred. A sodium bicarbonate concen-
tration of 2 mg/ml was optimal for visual and ﬂuorescence readings, because it boosted
color intensity and improved pH buffering (see Fig. S1 in the supplemental material).
The addition of 0.1 mg/ml esculin increased the ﬂuorescence signal by 2- to 4-fold (Fig.
S1). These observations support the use of sodium bicarbonate and esculin as useful
broth medium additives that are compatible with resazurin for Malassezia growth and
broth microdilution assays.
Optimal inoculum size for Malassezia spp. By testing a range of inoculum sizes
and varying the incubation time before the readings, we observed that the MIC values
of some antifungals depended strongly on the inoculum size and the incubation time,
while other antifungals were less affected. For amphotericin B, growth curves were not
inﬂuenced by the inoculum size or the incubation time (Fig. S2, left column). However,
growth curves were less reproducible with other antifungals, especially when an
inoculum of 100,000 CFU/ml was used. To provide reproducible results for all
antifungals, we decided to use a ﬁnal inoculum of 5.0  103 to 5.0  104 CFU/ml for
all tested Malassezia strains.
Incubation times of 18 to 48 h gave comparable growth curves, and MIC values
determined at those time points did not differ by more than 1 to 2 dilution steps for
inocula of 5.0  103 to 5.0  104 CFU/ml (Fig. S2, right column). Color development
after 6 to 12 h of incubation was insufﬁcient for reliable MIC readings, while the
ﬂuorescence signal faded after 60 h of incubation. Therefore, we decided to read the
plates after 24 to 48 h of incubation. Ketoconazole was the only exception, for which
incubation periods of 24 to 36 h resulted in a loss of growth curve sensitivity and high
MIC readings.
Agreement between visual and ﬂuorescence readings. We were interested in
assessing whether MIC values determined by visual readings differed from MIC values
determined by ﬂuorescence readings. MIC values determined by ﬂuorescence readings
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appeared slightly higher than those determined by visual readings, but the difference
was not signiﬁcant (P  0.25). Overall, the MIC values determined by the two readout
methods were strongly correlated with each other for all antifungals (Pearson’s corre-
lation coefﬁcients of 0.857 for all drugs) (Fig. 1). For most antifungals, MIC values
determined by the two methods were within 2 dilution steps in 96 to 100% of cases
(Table 2). The agreement of MIC values for ketoconazole was slightly lower, with MIC
values within 2 dilution steps in 88% of cases (Table 2).
Susceptibility of Malassezia spp. to antifungals. We assessed the antifungal
susceptibility proﬁles of 52 Malassezia strains, including 13 reference strains and 39
clinical strains (Table 3), with 11 antifungals commonly used in clinical practice. The
lowest MIC values were found for itraconazole, posaconazole, and voriconazole for
most strains tested (Fig. 2 and Table 4). Among the azoles, the highest MIC values and
FIG 1 (A) MIC values of antifungals (except griseofulvin and echinocandins) for 52 Malassezia strains,
determined by visual readings (x axis) and ﬂuorescence readings (y axis). Black circles represent points at
which the two data readings were in 100% agreement. The number of MIC values per data point in the graph
is indicated by the color bar. Agreement between visual and ﬂuorescence readings was determined by
Pearson correlation analysis. (B) Agreement between MIC values determined by visual readings and ﬂuores-
cence readings from a representative antifungal resistance assay plate testing M. sympodialis. Each row
represents a particular antifungal, with concentrations increasing from left to right. In the yellow box, the plus
sign indicates the positive control without antifungal and the minus sign indicates the negative control
containing broth medium without M. sympodialis. Pink wells indicate the growth of M. sympodialis, and blue
wells indicate no growth. The graph represents the ﬂuorescence readings of the color changes.
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the widest MIC ranges were observed for ﬂuconazole (Table 4; also see Table S1).
Ketoconazole showed low MICs for most strains but very high MICs for a few strains
(Fig. 2 and Table 4). MICs for terbinaﬁne and amphotericin B showed wide ranges; some
strains showed low MICs while others had very high MIC values. All strains had very
high MIC values for the echinocandins anidulafungin, caspofungin, and micafungin, as
well as griseofulvin, suggesting an intrinsic resistance of Malassezia spp. to these
antifungals (Fig. 2); therefore, MIC values for these antifungals are not shown in Tables
2 and 4. Two species, namely, the anthropophilicM. obtusa and the zoophilicMalassezia
caprae, appeared to be resistant to most antifungals (Fig. 2 and Table 4). Terbinaﬁne
was the only antifungal that was effective against M. caprae.
DISCUSSION
RPMI 1640 medium containing 0.165 M 3-(N-morpholino)propanesulfonic acid
(MOPS) buffer is the basis for the broth microdilution methods recommended by the
CLSI and EUCAST (6, 7). This broth is not optimal for the growth of fastidious fungi such
as Malassezia spp., which require lipid supplementation. By adding multiple compo-
nents, including lipids (such as oils and Tween compounds) and esculin, to our broth
medium, we facilitated the growth of Malassezia spp. We have named this new broth
medium OptiMAL. OptiMAL may also be suitable for other yeast species, such as
Candida, that utilize additives such as Tween compounds (13).
Resazurin (also known as alamarBlue) is used as an indicator in the colorimetric
YeastOne Sensititre assay (Thermo Scientiﬁc, Zug, Switzerland) for routine antifungal
susceptibility testing of yeasts and molds such as Candida spp. and Aspergillus spp. (14,
15). It changes from blue to pink as a result of growth (16) and allows for the visual and
spectrophotometric determination of MIC values. Until now, it has not been used in
broth media for Malassezia spp. because it is not always color stable during prolonged
incubation and therefore needs to be buffered (16, 17). The careful buffering of
OptiMAL with sodium bicarbonate and esculin allowed for the concurrent use of
resazurin as a color indicator. The use of esculin in OptiMAL improved the growth of all
Malassezia species by up to 4-fold (Fig. S1), and it was a key ingredient to improve the
TABLE 2 Agreement of MIC values from visual and ﬂuorescence readings
Agreement level
Agreement (%)
Amphotericin B Terbinaﬁne Ketoconazole Fluconazole Itraconazole Posaconazole Voriconazole
MICs identical 75 73 63 67 67 73 75
MICs within 1 dilution 96 94 84 88 88 94 96
MICs within 2 dilutions 98 96 88 96 98 100 98
TABLE 3Malassezia species and proposed inocula for antifungal susceptibility testing
Strain no. Species Host
No. of strains
tested
Reference
strain
OD600 for
inoculuma
1 M. sympodialis Human 24 CBS 7222 0.1
2 M. sloofﬁae Human 10 CBS 7956 0.05
3 M. furfur Human 5 CBS 1878 0.005
4 M. globosa Human 3 CBS 7966 0.2–1
5 M. restricta Human 2 CBS 7877 0.2–1
6 M. obtusa Human 2 CBS 7876 0.2–1
7 M. dermatis Human 1 CBS 9169 0.1
8 M. japonica Human 1 CBS 9432 0.2
9 M. yamatoensis Human 1 CBS 9725 0.02
10 M. nana Animal 1 CBS 9557 0.1
11 M. pachydermatis Animal 1 CBS 1879 0.01
12 M. cuniculi Animal 1 CBS 11721 0.1
13 M. caprae Animal 1 CBS 10434 0.1
aOD600 values for broth microdilution testing, as determined by plating 10 l of a 1:10 dilution to achieve
inocula of 104 to 105 CFU/ml. For the susceptibility assay, 50 l of inoculum was added to 50 l of 2
concentrations of antifungals, to achieve ﬁnal cell densities of 5.0  103 to 5.0  104 CFU/ml.
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accuracy and reproducibility of our assay. Studies on fungal growth usually omit
sodium bicarbonate because it causes growth inhibition of many fungal species (18).
We observed that Malassezia spp. grew well in OptiMAL containing 2 mg/ml sodium
bicarbonate. The bicarbonate served as a complementary buffer to MOPS; it boosted
the intensity of the resazurin color change and yielded higher sensitivity of ﬂuores-
cence detection.
The lack of standardized guidelines for drug susceptibility testing in Malassezia spp.
has led some studies (8, 9) to use small inocula, in accordance with the guidelines
FIG 2 MIC values of 11 antifungals for 52 Malassezia strains, as determined by visual readings. MIC values
were normalized from 0 to 1, with 1 being the highest antifungal concentration tested. The ﬁrst row for
eachMalassezia species represents the susceptibility proﬁle of the reference strain. Gray sections indicate
inconclusive MIC results.
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speciﬁed by the CLSI for yeasts (11), because overtly large inocula are associated with
inaccurate MIC values (19). However, the EUCAST guidelines for yeasts use a 100-fold
larger inoculum than do the CLSI guidelines. To test the relevance of these differences
between the CLSI and EUCAST guidelines for Malassezia spp., we performed inoculum
titration studies. We decided on 5.0 103 to 5.0 104 CFU/ml as the optimal inoculum
size for Malassezia broth microdilution assays, because this size gave reproducible MIC
values within 2 dilution steps for repeats with the same Malassezia strain. Ketoconazole
was particularly sensitive to variations in inoculum size and incubation time.
Visual readings for changes in color and turbidity are the most common form of MIC
determinations. Quantitative readings can be performed by measuring absorbance or
ﬂuorescence, with the latter being more sensitive (20). In general, visual determinations
of color changes may be preferable to absorbance or ﬂuorescence readings in labora-
tory practice, because they do not require additional technical equipment, are faster,
and therefore are cheaper (12). Few studies have investigated the agreement of MIC
values determined by visual and ﬂuorescence readings. For example, a comparison of
MIC values of azoles for 88 Aspergillus fumigatus isolates determined by absorbance and
visual turbidity reading were in good agreement (21). Neither absorbance nor turbidity
readings were an option in our assay, however, because (i) some very slow-growing
species such as M. furfur would have required much larger inocula than recommended
to visualize turbidity; (ii) the clumpiness of some species, such as M. globosa and M.
restricta, hampered reliable accurate absorbance or turbidity readings; and (iii) our
assay is based on resazurin, and turbidity readings are not recommended when
resazurin is used (22). Therefore, we decided to use visual color changes and ﬂuores-
cence readings to determine MIC values. Overall, our MIC values determined by visual
and ﬂuorescence readings were in good agreement. Slightly higher MIC values were
obtained with ﬂuorescence readings, presumably because of the higher sensitivity of
ﬂuorescence readings. These differences were generally within 1 to 2 dilution steps,
which is acceptable by CLSI and EUCAST standards. Our ﬁndings substantiate the
concordance of visual and ﬂuorescence readings for MIC values in resazurin-based
assays.
Despite the use of an optimized growth medium and a standardized inoculum size,
repeated testing (at least duplicates) showed that the azoles, and to a lesser extent
terbinaﬁne, might be prone to considerable test-to-test variations. In particular, keto-
conazole testing required more repeats. This may be attributable to (i) the antagoniza-
tion of medium components (10) and/or (ii) the susceptibility of ketoconazole to
variations in inoculum size and incubation time, as described above.
We have applied this optimized broth microdilution method to test the suscepti-
bility of 52 Malassezia strains to 11 antifungals. Our assay included the echinocandin
class as well as griseofulvin. The data showed that Malassezia is resistant to these
antifungals, which is in line with literature reports (3, 23). The azoles itraconazole,
posaconazole, and voriconazole appeared to be the most effective antifungals against
Malassezia spp. High MIC values for these azoles were rare, which is in line with
previous studies (10, 24). Most of our Malassezia strains were susceptible to concen-
trations of ﬂuconazole and ketoconazole described previously (7–9, 25). However, some
strains were resistant to ketoconazole. This could be of clinical signiﬁcance, because
ketoconazole is the ﬁrst-line topical antifungal in the treatment of Malassezia-
associated skin diseases such as pityriasis versicolor or seborrheic dermatitis (26).
Terbinaﬁne, a widely used allylamine, is active against dermatophytes and molds and
can be applied topically or systemically (27). It is not recommended as a ﬁrst-line
treatment for Malassezia-associated diseases (26). The relatively low MIC values of
terbinaﬁne against many of our Malassezia strains suggest that terbinaﬁne may be a
treatment alternative for Malassezia infections that do not respond to azoles.
In summary, we have developed an optimized broth microdilution assay, compat-
ible with the colorimetric indicator resazurin, for the fast and efﬁcient proﬁling of
antifungal susceptibility in Malassezia spp. Determinations of MIC values by visual
readings of color changes versus ﬂuorescence readings were comparably reliable.
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Among the 52 Malassezia strains tested, azoles such as voriconazole, itraconazole, and
posaconazole were the most effective antifungals. Terbinaﬁne might be a treatment
alternative for Malassezia infections.
MATERIALS AND METHODS
Malassezia strains. Malassezia reference strains were obtained from the Centraalbureau voor
Schimmelcultures (CBS) (Utrecht, The Netherlands) (Table 3). Clinical strains were obtained from patients
who were seen at the Department of Dermatology, University Hospital of Zurich (Zurich, Switzerland). All
strains were maintained on modiﬁed Leeming-Notman (mLN) agar and were identiﬁed as described
previously (28, 29).
Optimization of broth medium formulation. The basis of the broth medium was ﬁltered RPMI 1640
medium with 0.165 M MOPS without sodium bicarbonate (Sigma-Aldrich, Zurich, Switzerland). Sodium
bicarbonate, glucose, Tween 60, oleic acid, glycerin, and esculin (Sigma-Aldrich) were selectively titrated
and added to the broth medium. Reference strains of M. sympodialis, M. sloofﬁae, M. furfur, M. globosa,
and M. pachydermatis were inoculated in triplicate at the stipulated optical density (OD) (Table 3) and
incubated for 48 h at 35°C. Growth was assessed by scoring the turbidity of the broth medium on an
arbitrary scale ranging from 0 (no growth) to 4 (highest growth). This led to the formulation of three
candidate media (Table 5). RPMI with esculin provided the best conditions for growth and colori-
metric readings for all tested Malassezia strains. We have named this medium OptiMAL and used it for
antifungal susceptibility testing.
Malassezia inoculum quantiﬁcation and optimization. Malassezia inocula were quantiﬁed in
suspension by measurements of the OD at 600 nm (OD600) (Cytation 3 plate reader; BioTek, Winooski, VT,
USA). To correlate OD600 readings with the numbers of yeast cells, serial dilutions of the suspensions were
plated on mLN agar at 35°C and the CFU were counted after 4 to 7 days.
To determine the optimal inoculum range for Malassezia spp., ﬁve different inocula (approximately
2,500, 5,000, 50,000, 100,000, and 200,000 CFU/ml) of M. furfur CBS 1878 were tested together with seven
antifungals (amphotericin B, terbinaﬁne, ketoconazole, ﬂuconazole, itraconazole, posaconazole, and
voriconazole). Plates were read every 6 h for the ﬁrst 24 h and subsequently at 12-h intervals for up to
60 h, as described below.
Broth microdilution assay. Antifungals tested in the assay were amphotericin B (concentration
range, 0.06 to 8 g/ml), caspofungin (0.06 to 8 g/ml), griseofulvin (0.06 to 8 g/ml), terbinaﬁne (0.125
to 16 g/ml), ﬂuconazole (0.06 to 128 g/ml), ketoconazole (0.03 to 4 g/ml), itraconazole (0.015 to 8
g/ml), posaconazole (0.015 to 8 g/ml), voriconazole (0.003 to 8 g/ml) (all from Sigma-Aldrich),
micafungin, and anidulafungin (all from MedChemExpress Europe, Sollentuna, Sweden). Serial 2-fold
dilutions of 200 stocks of antifungals were prepared in dimethyl sulfoxide (DMSO) (Sigma-Aldrich) and
stored at 80°C. Inocula (50 l) were added to 50 l of 2 concentrated antifungals to achieve a ﬁnal
cell density of 5.0  103 to 5.0  104 CFU/ml. For inoculum veriﬁcation, 10 l of a 1:10 diluted inoculum
was plated onto mLN agar and incubated for 4 to 7 days at 35°C. MIC values from each well plate were
deemed reliable only if counts on agar plates were within 10 to 100 CFU.
Candida parapsilosis ATCC 22019 was used as a quality control strain to assess the accuracy of our
antifungal dilutions and the reproducibility of results for ﬂuorescence and visual readings, according to
CLSI (11) and EUCAST (http://www.eucast.org) guidelines.
Analysis of antifungal susceptibility assay data. Plates were analyzed when the indicator resazurin
(Sigma-Aldrich) changed from blue to pink in the positive control. The color change was assessed by (i)
visual reading and (ii) ﬂuorescence analysis at 530 nm and 590 nm (Cytation 3 plate reader). Growth was
measured relative to the positive control. MIC values for azoles and echinocandins were deﬁned as 50%
growth inhibition and those for amphotericin B as complete growth inhibition, in accordance with CLSI
standards (11). For terbinaﬁne, the MIC was deﬁned as the lowest drug concentration that completely
inhibited growth.
TABLE 5 Broth media for Malassezia spp.
Component RPMIa RPMI 
RPMI with esculin
(OptiMAL)
MOPS (M) 0.165 0.165 0.165
Sodium bicarbonate (mg/ml) 0.2 0.2 0.2
Glucose (% of volume) 2 2 2
Glycerol (% of volume) 0.1 1 0.5
Glycerol monostearate (% of volume) 0.05
Tween 20 (% of volume) 0.04
Tween 60 (% of volume) 0.5 0.5
Olive oil
Oleic acid (% of volume) 2 2
Esculin (% of volume) 0.1
Resazurin (g/ml) 12.5 12.5 12.5
pH 6.32 6.25 6.26
aAdapted from Velegraki et al. (8).
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For each strain, at least duplicate testing was performed. If the MIC values differed by more than 2
dilution steps, then experiments were repeated. In cases in which repeat testing gave MIC values on
extreme ends of the dilution scale, an inconclusive MIC result was recorded.
Heat maps of the ﬁnal MIC values for each strain were plotted using the minimum and maximum
drug ranges tested, normalized on a scale of 0 to 1. Analysis of variance (ANOVA) and correlation analysis
were applied by calculating Pearson’s r values. Inferential statistics were calculated with StatPlus:mac
2016 (AnalystSoft Inc., Walnut, CA, USA), and P values of 0.05 were considered signiﬁcant.
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